Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

L Dreyer; M Magyari; B. Laursen; R Cordtz; F Sellebjerg; H. Locht

doi:10.1136/annrheumdis-2015-208490

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

L Dreyer, M Magyari, B. Laursen, R Cordtz, F Sellebjerg, H. Locht

IKM

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

36 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	75
Udgave nummer	4
Sider (fra-til)	785-6
Antal sider	2
ISSN	0003-4967
DOI	https://doi.org/10.1136/annrheumdis-2015-208490
Status	Udgivet - apr. 2016

Adgang til dokumentet

10.1136/annrheumdis-2015-208490

Citationsformater

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis : a population-based study from DANBIO and the Danish Multiple Sclerosis Registry. / Dreyer, L; Magyari, M; Laursen, B.; Cordtz, R; Sellebjerg, F; Locht, H.

I: Annals of the Rheumatic Diseases, Bind 75, Nr. 4, 04.2016, s. 785-6.

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

@article{971920ee231945f5b72fc6b177ca5538,

title = "Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry",

keywords = "Adult, Aged, Antirheumatic Agents, Arthritis, Psoriatic, Arthritis, Rheumatoid, Denmark, Female, Humans, Incidence, Male, Middle Aged, Multiple Sclerosis, Registries, Risk Factors, Spondylitis, Ankylosing, Tumor Necrosis Factor-alpha, Letter, Research Support, Non-U.S. Gov't",

author = "L Dreyer and M Magyari and B. Laursen and R Cordtz and F Sellebjerg and H. Locht",

year = "2016",

month = apr,

doi = "10.1136/annrheumdis-2015-208490",

language = "English",

volume = "75",

pages = "785--6",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "4",

}

TY - JOUR

T1 - Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis

T2 - a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

AU - Dreyer, L

AU - Magyari, M

AU - Laursen, B.

AU - Cordtz, R

AU - Sellebjerg, F

AU - Locht, H.

PY - 2016/4

Y1 - 2016/4

KW - Adult

KW - Aged

KW - Antirheumatic Agents

KW - Arthritis, Psoriatic

KW - Arthritis, Rheumatoid

KW - Denmark

KW - Female

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Multiple Sclerosis

KW - Registries

KW - Risk Factors

KW - Spondylitis, Ankylosing

KW - Tumor Necrosis Factor-alpha

KW - Letter

KW - Research Support, Non-U.S. Gov't

U2 - 10.1136/annrheumdis-2015-208490

DO - 10.1136/annrheumdis-2015-208490

M3 - Letter

C2 - 26698850

VL - 75

SP - 785

EP - 786

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 4

ER -